Risk of Feeding Problems Among Infants With Neonatal Abstinence Syndrome: A Retrospective Cohort Study

Nana A Mensah1, Erin F Madden, Fares Qeadan

  • 1Department of Family and Preventive Medicine, University of Utah, Salt Lake City (Ms Mensah and Dr Qeadan); and Department of Family Medicine and Public Health Sciences, Wayne State University, Detroit, Michigan (Dr Madden).

Insights

Infants with neonatal abstinence syndrome (NAS) are almost three times more likely to experience feeding problems. This highlights the need for specialized feeding interventions for these vulnerable infants.

Area of Science:

  • Neonatal care
  • Pediatric nutrition
  • Public health

Background:

  • Neonatal Abstinence Syndrome (NAS) incidence surged over 500% from 2004-2016.
  • Feeding issues in infants with NAS are documented but not quantified.
  • The precise risk of feeding problems in NAS infants remains unestimated.

Purpose of the Study:

  • To quantify the risk of feeding problems in infants diagnosed with NAS.
  • To compare feeding problem incidence in infants with and without NAS.

Main Methods:

  • Retrospective cohort study (2008-2017) using US hospital admission data.
  • Matched analysis of infants with and without NAS diagnoses.
  • Multivariable logistic regression to identify associations with feeding problems.

Main Results:

  • Infants with NAS were 2.81 times more likely to have feeding problems (OR=2.81; 95% CI, 2.68-2.95).
  • Lower birth weight, older infant age, Hispanic ethnicity, and Midwest location were associated with increased feeding problem risk.
  • NAS infants with feeding issues had lower odds of receiving lactation services.

Conclusions:

  • Findings indicate a significantly higher risk for feeding problems in infants with NAS.
  • Targeted feeding interventions are crucial for infants diagnosed with NAS.
  • Further research should explore maternal factors influencing NAS and feeding difficulties.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
65
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
607